Palisade Bio (PALI) Cash from Financing Activities (2016 - 2025)
Palisade Bio has reported Cash from Financing Activities over the past 16 years, most recently at $131.3 million for Q4 2025.
- Quarterly Cash from Financing Activities rose 3055.48% to $131.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $134.4 million through Dec 2025, up 1303.05% year-over-year, with the annual reading at $134.4 million for FY2025, 1303.05% up from the prior year.
- Cash from Financing Activities was $131.3 million for Q4 2025 at Palisade Bio, up from $3.4 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $131.3 million in Q4 2025 and troughed at -$258000.0 in Q1 2025.
- The 5-year median for Cash from Financing Activities is $1.7 million (2022), against an average of $10.1 million.
- Year-over-year, Cash from Financing Activities skyrocketed 5203.45% in 2023 and then crashed 112.75% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at $1.2 million in 2021, then soared by 48.78% to $1.7 million in 2022, then tumbled by 107.82% to -$134000.0 in 2023, then skyrocketed by 3205.97% to $4.2 million in 2024, then soared by 3055.48% to $131.3 million in 2025.
- Per Business Quant, the three most recent readings for PALI's Cash from Financing Activities are $131.3 million (Q4 2025), $3.4 million (Q3 2025), and $4000.0 (Q2 2025).